SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-097603
Filing Date
2021-07-29
Accepted
2021-07-29 16:31:05
Documents
14
Period of Report
2021-07-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2123591d1_8k.htm   iXBRL 8-K 33624
2 EXHIBIT 10.1 tm2123591d1_ex10-1.htm EX-10.1 13617
6 GRAPHIC tm2123591d1_ex10-1img001.jpg GRAPHIC 12334
  Complete submission text file 0001104659-21-097603.txt   243712

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA supn-20210723.xsd EX-101.SCH 3188
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE supn-20210723_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE supn-20210723_pre.xml EX-101.PRE 22712
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2123591d1_8k_htm.xml XML 3496
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 211127877
SIC: 2834 Pharmaceutical Preparations